Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Formation method of drug coating and drug coating prepared by same

A technology of drug coating and drug molecules, applied in the field of medicine, can solve problems such as narrow space

Active Publication Date: 2013-03-27
PUYI (SHANGHAI) BIOTECHNOLOGY CO LTD
View PDF5 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, the space in the nasal cavity is narrow, and even non-irritating solvents cannot volatilize smoothly, leaving only effective drugs and controlled-release polymers to form a good coating, and it will only flow out of the nasal cavity like the existing nasal irrigation solution. to a reasonable stay

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Formation method of drug coating and drug coating prepared by same
  • Formation method of drug coating and drug coating prepared by same
  • Formation method of drug coating and drug coating prepared by same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1 Solid particle mixture according to one embodiment of the present invention

no. 1 approach

[0052] According to the first embodiment of the present invention, the drug coating formed by the mixture of solid particles can be formed by physical cross-linking of a single solid particle in a wet state. At this time, the "single solid particle" refers to a solid particle with the same form of expression. In this embodiment, the solid particle is a uniformly dispersed particle 2, such as figure 2 shown.

[0053] Usually, the solid particles at least include drug molecules and polymers, and the polymers can be a degradable hydrophilic / water-soluble polymer, or a combination of degradable polymers and hydrophilic / water-soluble polymers. mixture. Wherein, the drug molecules are uniformly dispersed in the polymer. For example in figure 2 and image 3 In , the number 21 indicates the degradable polymer, the number 22 indicates the hydrophilic / water-soluble polymer, and the number 23 indicates the drug molecule.

[0054] The method of forming the microparticles in uniform...

Embodiment 2

[0067] Example 2 Solid particle mixture according to another embodiment of the present invention

[0068] According to the second embodiment of the present invention, the drug coating formed by the mixture of solid particles can be formed by physical cross-linking of a single solid particle in a wet state. At this time, the "single solid particle" refers to a solid particle with the same form of expression. In this embodiment, the solid particle is a particle 3 in the form of a skin-core, such as Figure 7 shown.

[0069] Usually, the solid particles at least include drug molecules and polymers, and the polymers can be a degradable hydrophilic / water-soluble polymer, or a combination of degradable polymers and hydrophilic / water-soluble polymers. mixture. Wherein, the drug molecules are uniformly dispersed in the polymer. For example in Figure 7 In , the number 31 represents a degradable polymer, the number 32 represents a hydrophilic / water-soluble polymer, and the number...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a formation method of a drug coating. The formation method comprises the following steps in sequence: providing at least one dried solid particle, wherein the dried solid particle comprises polymers and drug molecules; spraying a dried solid particle mixture formed by the dried solid particles on a moist surface, wherein the polymers are swelled on the moist surface, so that the physical crosslinking can be carried out between the solid particles so as to form the drug coating; or spraying the dried solid particle mixture formed by the dried solid particles on a dried surface, and then spraying atomized water drops on the surface of the dried solid particle mixture, wherein the polymers are swelled to result in physical crosslinking between the solid particles so as to form the drug coating. The drug coasting provided by the invention has the advantages that the slow release time can be controlled to reach 1 to 90 days, and preferably 3 to 30 days, so that the drug coating can be kept on the surface of a lesion part for a long time in order to come into play for a long time, and as a result, the nasal diseases such as nasosinusitis and allergic rhinitis can be treated better.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a method for forming a drug coating and the drug coating. Background technique [0002] Sinusitis and allergic rhinitis are common and frequently-occurring diseases of ENT, which occur between the ages of 5 and 79. According to the survey by the health department: the current global incidence of allergic rhinitis is as high as 10% to 14%, and the incidence of sinusitis accounts for about 15% of the population. Nearly 600 million people in the world are suffering from rhinitis, and it is gradually Upward trend. [0003] 66% of asthma patients are victims of allergic rhinitis. According to experts, if allergic rhinitis is not properly treated, more than one-third of patients will eventually develop asthma. [0004] Nasal sinuses, also known as paranasal sinuses and paranasal sinuses, are multiple air-containing bony cavities around the nasal cavity, which communicate with the nasal cavit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/16A61K9/70A61K47/30A61P11/02
Inventor 谢建魏征
Owner PUYI (SHANGHAI) BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com